Sharp Dip in US Drug Approvals Forecast
July 30, 2012 | The US Food and Drug Administration (FDA) will approve fewer novel drugs in 2012 than it did last year, as the industry faces a number of ongoing operational risks, according to a new report. Pharma Times
